Today: 23 May 2026
Denison Mines stock jumps nearly 11% as Phoenix uranium project nears build decision
2 January 2026
2 mins read

Denison Mines stock jumps nearly 11% as Phoenix uranium project nears build decision

NEW YORK, January 2, 2026, 10:05 ET — Regular session

  • Denison Mines shares climbed after the company said it is ready to start construction on its Phoenix ISR uranium mine, pending final approvals.
  • Denison lifted its post-investment initial capital estimate for Phoenix to about C$600 million.
  • Investors are watching for a federal licence decision in Canada and the company’s final investment decision timeline.

Denison Mines rose 10.9% to $2.95 in morning trade on Friday after the uranium developer said it is ready to make a final investment decision and begin construction on its flagship Phoenix project, while raising its upfront build budget.

The update matters now because Phoenix is moving from planning into execution, a phase where timelines and budgets tend to drive stock moves more than long-range resource estimates.

It also puts the next catalyst squarely on regulators: Denison needs federal sign-off in Canada before it can break ground, and the company is pointing to early 2026 as a decision window.

Denison said it is ready to make a final investment decision — the formal go-ahead to build — and commence construction of the Phoenix in-situ recovery (ISR) mine after receiving final regulatory approvals. ISR is a mining method that circulates solution through the ore body and pumps it to the surface, rather than digging an open pit.

The company reiterated an expected two-year construction schedule and said first production remains targeted for mid-2028 if approvals to commence construction are received in the first quarter of 2026.

Denison raised its post-FID initial capital estimate — the upfront capital expenditure, or capex — to about C$600 million, and said the budget includes about C$65 million in contingency and owners’ reserves. The company said the revised figure is about 20% higher than its 2023 feasibility study after adjusting for inflation.

“Denison stands ready to make a final investment decision and commence construction of the Phoenix ISR mine,” President and Chief Executive David Cates said. PR Newswire

Denison said the Canadian Nuclear Safety Commission’s two-part public hearing on its environmental assessment and construction licence concluded on Dec. 11, and it is awaiting a decision. The company also said Saskatchewan has authorized certain early earthworks such as vegetation removal and site drainage.

On project economics, Denison said its base-case after-tax net present value — a way of translating future cash flows into today’s dollars — is about C$1.57 billion at an 8% discount rate under the updated capex, while after-tax internal rate of return, a profitability metric, is 73%.

Uranium-linked stocks were broadly higher on Friday, with Cameco up 6.7%, Uranium Energy up 9.5% and Energy Fuels up 9.5%. The Global X Uranium ETF rose 5.7% and the Sprott Uranium Miners ETF gained 7.3%.

Traders will focus next on the federal licence decision and on whether Denison locks in construction contracts and a final investment decision on the schedule it outlined. Denison said its updated analysis also reflects higher long-term uranium pricing assumptions, citing a UxC month-end term price estimate of $86 per pound of U3O8 (uranium oxide) as of Dec. 31, 2025.

Stock Market Today

  • Q1 Earnings Review: The Ensign Group (ENSG) Trails Healthcare Providers & Services Peers
    May 22, 2026, 11:54 PM EDT. Healthcare providers & services stocks delivered a solid Q1, with revenues beating estimates by 1.4% and shares rising 9.6% on average. The Ensign Group (NASDAQ:ENSG) reported $1.39 billion in revenue, up 18.4% year-over-year but missing analyst expectations by 8.4%. ENSG's stock fell 4.9% post-earnings, marking the weakest performance among its peers. Sector challenges include high operational costs and reimbursement pressures, yet an aging population and healthcare digitization provide growth opportunities. CEO Barry Port emphasized the company's focus on quality care and managing complex patient cases. Despite ENSG's miss, the sector outlook remains cautiously optimistic amid ongoing regulatory and labor headwinds.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand
Previous Story

ASML shares jump after surprise Aletheia upgrade flips outlook on EUV demand

IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar
Next Story

IBM’s 2026 quantum milestone puts IonQ and Nvidia back on investors’ radar

Go toTop